Virtual Medicinal Product (VMP)
-
Theophylline 125mg modified-release capsules
Name Details
Current Name
Theophylline 125mg modified-release capsules
|
Start Date
06-11-2002
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- capsule
- Unit Dose UOM
- capsule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Modified-release capsule
- Ontology Form/Route
- capsulemodified-release.oral
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- BAN - British Approved Name
Codes
- ATC Code
-
R03DA04
BNF |
Current BNF
03010300
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
03010300
|
Start Date
31-01-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
35957711000001104 |
23-10-2018 |
|
320420003 |
06-11-2002 |
22-10-2018 |
VMP Ingredients
VMP ingredients table
Theophylline |
Based on Ingredient Substance |
|
125 mg |
|
Name
Theophylline
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
125
Strength and UOM (Dmr)
Parent Products
-
VTM
Theophylline
-
VMP
(Current) Theophylline 125mg modified-release ...
Virtual Medicinal Product Pack (VMPP) Information